Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)

NCT00211315 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Coat's Disease

Interventions

DRUG: anecortave acetate

Sponsor

Manhattan Eye, Ear & Throat Hospital

Collaborators

[object Object]